Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mesoblast Ltd (NASDAQ:MESO)

7.30
Delayed Data
As of Aug 18
 -0.11 / -1.48%
Today’s Change
4.01
Today|||52-Week Range
12.50
+36.45%
Year-to-Date
No recent news for Mesoblast Ltd.

Today’s Trading

Previous close7.41
Today’s open7.34
Day’s range7.19 - 7.34
Volume6,909
Average volume (3 months)26,242
Market cap$619.7M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+96.32%
Earnings growth (this year)-430.45%
Earnings growth (next 5 years)-0.34%
Revenue growth (last year)+143.13%
P/E ratio--
Price/Sales6.89
Price/Book1.04

Competitors

 Today’s
change
Today’s
% change
IVCInvacare Corp+0.09+0.67%
OFIXOrthofix Internation...+0.56+1.18%
RTIXRTI Surgical Inc-0.05-1.06%
SIENSientra Inc-0.09-0.86%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateAugust 23, 2017
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$41.5M
Annual profit (last year)-$4.1M
Net profit margin-9.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, MD &
Executive Director
Silviu Itescu
Chief Financial Officer
Paul Hodgkinson
Corporate headquarters
Melbourne, Victoria (vic)

Forecasts